## Abstract The identification of the widespread deposition of fibrillized Ξ±βsynuclein in Lewy bodies and Lewy neurites in the brains of patients with Parkinson's disease in 1997 has had a profound impact on how the disease is now conceptualized. The previous focus on the loss of the dopaminergic n
Dystonia in parkinson's disease: Clinical and pharmacological features
β Scribed by Dr. W. H. Poewe; A. J. Lees; G. M. Stern
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 596 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In many areas of medicine, the focus has shifted from treating existing disease to screening and prevention. The technology to screen for Parkinson's disease (PD) already exists. The current challenge is to define the appropriate use of predictive testing for PD. Imaging technologies cu
## Abstract Hedonistic homeostatic dysregulation (HHD) is a neuropsychiatric disorder recently described in Parkinson's disease (PD), which is characterized by selfβmedication and addiction to dopaminergic drugs. To understand the prevalence of this disorder, we screened 202 PD patients attending o
Dystonia can be a heralding symptom of Parkinson's disease (PD), but more frequently occurs as a levodopa-induced phenomenon during the course of sustained treatment. "Off" period dystonia is the most common form and mainly affects the feet; peak-dose dystonia occurs predominantly in the face/ neck,